Top 10 Companies in the (R)-(-)-Glycidyl butyrate (CAS No. 60456-26-0) Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global (R)-(-)-Glycidyl butyrate (CAS No. 60456-26-0) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(R)-(-)-Glycidyl butyrate is a chiral epoxide ester compound recognized for its high optical purity and reactivity, making it a valuable building block in asymmetric synthesis and pharmaceutical manufacturing. The compound is characterized by its (R)-configuration glycidol backbone esterified with butyric acid, conferring it with distinct stereospecific properties that are critical in the synthesis of enantiomerically pure active pharmaceutical ingredients (APIs), agrochemicals, and specialty fine chemicals.

Demand for this compound is steadily rising, primarily driven by the pharmaceutical industry’s growing reliance on chiral intermediates to develop stereoselective drug candidates with improved efficacy and reduced side effects. Furthermore, advancements in enzymatic resolution and asymmetric catalysis techniques are expanding the compound’s applicability across diverse end‑use sectors, reinforcing its relevance in modern synthetic chemistry workflows.

(R)-(-)-Glycidyl butyrate (CAS No. 60456-26-0) Market – View in Detailed Research Report

🔟 10. Finetech Industry Limited

Headquarters: Shanghai, China
Key Offering: Pharmaceutical Grade (R)-(-)-Glycidyl butyrate, enzymatic resolution kits

Finetech Industry Limited has established itself as a leading provider of high‑purity chiral epoxides, leveraging proprietary lipase‑based resolution processes that achieve >99% enantiomeric excess. Their focus on scalable, continuous‑flow synthesis enables cost‑effective production for pharmaceutical R&D and custom synthesis projects.

Sustainability & Growth Initiatives:

• Investing in green biocatalytic processes to reduce solvent usage by 30%.
• Expanding capacity in Shanghai Chemical Park to meet growing demand from Asia‑Pacific pharma.
• Collaborating with academic institutions for next‑generation chiral catalysts.

🛑 9. Capot Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: High‑purity (R)-(-)-Glycidyl butyrate, custom synthesis services

Capot Chemical Co., Ltd. specializes in enzymatic resolution of racemic glycidyl butyrate, delivering >99% ee products to pharmaceutical and fine‑chemical customers. Their state‑of‑the‑art continuous‑flow reactors provide scalable output with minimal waste.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for butyric acid synthesis.
• Implementation of closed‑loop solvent recovery systems.
• Partnerships with regional universities for catalyst development.

🛑 8. Hairui Chemical Co., Ltd.

Headquarters: Chengdu, China
Key Offering: Laboratory Grade (R)-(-)-Glycidyl butyrate, analytical kits

Hairui Chemical focuses on supplying high‑purity epoxides for academic and industrial research, providing rigorous quality control and rapid turnaround for custom orders.

Sustainability & Growth Initiatives:

• Use of bio‑derived butyric acid to reduce carbon footprint.
• Optimizing reaction conditions to cut energy consumption by 20%.
• Engagement with local regulators to streamline compliance.

🛑 7. Shanghai Hanhong Scientific Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Ultra‑high purity (R)-(-)-Glycidyl butyrate, GMP‑certified production

Shanghai Hanhong Scientific delivers chiral epoxides that meet stringent GMP and ISO 9001 standards, catering to pharmaceutical manufacturers requiring certified intermediates.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient continuous‑flow reactors.
• Investment in waste‑minimization protocols.
• Collaboration with industry consortia to promote green chemistry.

🛑 6. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical Grade (R)-(-)-Glycidyl butyrate, analytical services

Tokyo Chemical Industry provides ultra‑pure chiral epoxides with ISO 9001 and GMP certifications, supporting high‑value pharmaceutical development in Asia and Europe.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources for production.
• Development of low‑toxicity solvents for epoxide synthesis.
• Participation in global sustainability initiatives.

🛑 5. Merck KGaA (Sigma‑Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical Grade (R)-(-)-Glycidyl butyrate, research reagents

Merck KGaA’s Sigma‑Aldrich division supplies high‑purity epoxides to pharmaceutical and academic markets, offering comprehensive analytical support and custom synthesis.

Sustainability & Growth Initiatives:

• Integration of AI‑driven process optimization.
• Commitment to carbon neutrality by 2030.
• Collaboration with EU green chemistry programs.

🛑 4. Biosynth Carbosynth

Headquarters: Switzerland
Key Offering: Custom synthesis of chiral intermediates, including (R)-(-)-Glycidyl butyrate

Biosynth Carbosynth specializes in bespoke chiral syntheses for early‑stage drug discovery, providing rapid turnaround and high‑quality standards.

Sustainability & Growth Initiatives:

• Use of biocatalysts to reduce hazardous reagents.
• Investment in scalable micro‑reactor technology.
• Participation in Swiss green chemistry initiatives.

🛑 3. Enamine LLC

Headquarters: Kyiv, Ukraine
Key Offering: Custom scale‑up services, library synthesis of (R)-(-)-Glycidyl butyrate derivatives

Enamine offers rapid scale‑up and library synthesis for academic and industrial clients, focusing on cost‑effective, high‑purity chiral intermediates.

Sustainability & Growth Initiatives:

• Development of renewable feedstock routes.
• Implementation of waste‑recycling programs.
• Collaboration with European research networks.

🛑 2. Apollo Scientific Ltd.

Headquarters: London, UK
Key Offering: High‑purity (R)-(-)-Glycidyl butyrate, analytical kits

Apollo Scientific delivers GMP‑grade epoxides for pharmaceutical R&D, with a focus on rapid delivery and stringent quality controls.

Sustainability & Growth Initiatives:

• Use of green solvents and catalysts.
• Energy‑efficient production processes.
• Engagement in UK green chemistry policy forums.

🛑 1. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Industrial Grade (R)-(-)-Glycidyl butyrate, bulk supply

Shanghai Trustin provides large‑volume, cost‑effective chiral epoxides for fine‑chemical manufacturers, leveraging efficient enzymatic resolution methods.

Sustainability & Growth Initiatives:

• Scaling up continuous‑flow reactors to reduce waste.
• Adoption of renewable energy sources.
• Partnerships with local universities for process innovation.

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of (R)-(-)-Glycidyl butyrate (CAS No. 60456-26-0) Market

The market is poised for sustained growth driven by increasing demand for single‑enantiomer therapeutics, expansion of enzymatic resolution technologies, and a global shift toward greener manufacturing practices. Regions such as Asia‑Pacific will continue to dominate due to cost‑effective production and robust biotech ecosystems, while North America and Europe will maintain high‑value niche markets supported by stringent regulatory standards.

📈 Key Trends Shaping the Market:

• Rapid adoption of continuous‑flow biocatalytic processes to lower production costs.
• Integration of AI‑driven process optimization for chiral synthesis.
• Growing use of (R)-(-)-Glycidyl butyrate as a building block in polymer and agrochemical development.
• Expansion of custom synthesis services to meet the needs of emerging therapeutic areas.

These trends position the market for a balanced growth trajectory, with high‑margin segments in pharmaceutical intermediates and expanding opportunities in specialty fine chemicals.